CawachiTSE:2664 -0.71%61 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates TSE:2664 with a GF Score™ of 61/100 and a GF Value™ of 円2,712.48 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Cawachi ranks worse than 54.86% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cawachi's Free Cash Flow for the
three
months ended in Mar. 2026 was 円0 Mil. Cawachi's Revenue for the
three
months ended in Mar. 2026 was 円69,506 Mil. Therefore, Cawachi's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Cawachi's FCF Margin % or its related term are showing as below:
TSE:2664'
s FCF Margin % Range Over the Past 10 Years
Min: 0.36 Med: 1.35 Max: 4.25
Current: 1.6
During the past 13 years, the highest FCF Margin % of Cawachi was 4.25%. The lowest was 0.36%. And the median was 1.35%.
TSE:2664's FCF Margin % is ranked worse than 54.86% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.39
vs TSE:2664: 1.60
Cawachi FCF Margin % Related Terms
Cawachi FCF Margin % Historical Data
* Premium members only.
The historical data trend for Cawachi's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Cawachi's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cawachi FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cawachi's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Cawachi's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cawachi (TSE:2664) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cawachi and its competitors. Over the past decade, Cawachi's FCF Margin % has ranged from 0.36 to 4.25. According to the industry distribution chart, Cawachi ranks #367 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 54.9%.
Is Cawachi's FCF Margin % too high?
Cawachi's current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 4.25. Based on the distribution chart, Cawachi ranks #367 out of 669 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Cawachi has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cawachi's FCF Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Cawachi ranks #367 out of 669 companies for FCF Margin %. This places Cawachi in the lower half of its industry. The industry median FCF Margin % is 3.39. Historically, Cawachi's own FCF Margin % has ranged from 0.36 to 4.25 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cawachi and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cawachi's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cawachi stock overvalued right now?
Based on GuruFocus' analysis, Cawachi (TSE:2664) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,712.48, compared to a current price of 円3,485.00 — trading 28.5% above its estimated fair value. The current FCF Margin % is 0.00%. Cawachi's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cawachi (TSE:2664), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cawachi (TSE:2664) Overvalued in 2026?
Based on GuruFocus' analysis, Cawachi stock appears to be overvalued.
The current stock price of 円3,485.00 is trading 28.5% above its estimated GF Value™ of 円2,712.48.
GuruFocus considers Cawachi to be Modestly Overvalued.
Key valuation signals for TSE:2664:
FCF Margin %: 0.00%
GF Value™: 円2,712.48 vs. price of 円3,485.00 (28.5% above fair value)
No single metric tells the full story. See the TSE:2664 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cawachi Ltd is a drug store operator based in Japan. The firm primarily sells pharmaceutical-related products to its customers. It also sells health foods, child care products, cosmetics, grocery, general food and confectionery through its retail outlets. The company operates over 300 stores across Japan.
61GF Score
Get the complete analysis for TSE:2664
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2664 has been successfully added to your 
